Bill Sponsor
House Bill 6645
116th Congress(2019-2020)
To direct the Secretary of Health and Human Services, acting through the Director of the National Institute of Mental Health, to conduct or support research on the mental health consequences of SARS-CoV-2 or COVID-19, and for other purposes.
Introduced
Introduced
Introduced in House on Apr 28, 2020
Overview
Text
Introduced in House 
Apr 28, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Apr 28, 2020)
Apr 28, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 6645 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 6645


To direct the Secretary of Health and Human Services, acting through the Director of the National Institute of Mental Health, to conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

April 28, 2020

Mr. Tonko introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To direct the Secretary of Health and Human Services, acting through the Director of the National Institute of Mental Health, to conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Research on the mental health impact of COVID-19.

(a) In general.—The Secretary of Health and Human Services (in this section referred to as the “Secretary”), acting through the Director of the National Institute of Mental Health, shall conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19.

(b) Use of funds.—Research under subsection (a) may include—

(1) research on the mental health impact of SARS–CoV–2 or COVID–19 on health care providers, including—

(A) traumatic stress;

(B) psychological distress; and

(C) psychiatric disorders; and

(2) research on the impact of SARS–CoV–2 or COVID–19 stressors on mental health over time;

(3) research to strengthen the mental health response to SARS–CoV–2 or COVID–19, including adapting to and maintaining or providing additional services for new or increasing mental health needs;

(4) research on the reach, efficiency, effectiveness, and quality of digital mental health interventions;

(5) research on the effectiveness of strategies for implementation and delivery of evidence-based mental health interventions and services for underserved populations; and

(6) research on suicide prevention.

(c) Research coordination.—The Secretary shall coordinate activities under this section with similar activities conducted by national research institutes and centers of the National Institutes of Health to the extent that such institutes and centers have responsibilities that are related to the mental health consequences of SARS–CoV–2 or COVID–19.

(d) Authorization of appropriations.—To carry out this section, there is authorized to be appropriated $100,000,000 for each of fiscal years 2021 through 2025, to remain available until expended.